In vitro susceptibility of typhoidal Salmonellae against newer antimicrobial agents: A search for alternate treatment options

Saba Qaiser, Seema Irfan, Erum Khan, Tanwir Ahsan, Afia Zafar

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Objectives: To determine the minimum inhibitory concentrations (MICs) of ceftriaxone, azithromycin, pefloxacin, cefipime and imipenem for Salmonella Typhi (S. Typhi) and Paratyphi. Methods: One hundred and fifty four isolates of Salmonella Typhi and S. Paratyphi A, B and C growing in blood culture were selected. MICs of ceftriaxone, azithromycin, pefloxacin, cefipime and imipenem were performed byagar dilution method as recommended by clinical laboratory standard institutes. Results: MIC90 of azithromycin and pefloxacin was 8 μg/ ml, cefipime was 0.06 μg/ ml and imipenem was0.5μg/ml. None of the strains were found to be resistant to ceftriaxone but 3 isolates showed higher MIC value of 2μg/ml.Conclusion: Azithromycin appears a suitable alternate for the treatment of typhoid in the community. Imipenemand cefipime are good options in complicated cases to be treated in hospital settings. Pefloxacin cannot be used as MICs are higher. Presence of isolates with higher MIC of ceftriaxone is serious and stresses upon continuous laboratory surveillance to guide clinicians appropriately.

Original languageEnglish
Pages (from-to)462-465
Number of pages4
JournalJournal of the Pakistan Medical Association
Volume61
Issue number5
Publication statusPublished - May 2011

Keywords

  • Drug resistance
  • New options
  • Typhoidal salmonellae

Fingerprint

Dive into the research topics of 'In vitro susceptibility of typhoidal Salmonellae against newer antimicrobial agents: A search for alternate treatment options'. Together they form a unique fingerprint.

Cite this